Soluble Levels of Receptor for Advanced Glycation Endproducts (sRAGE) and Coronary Artery Disease
- 1 May 2005
- journal article
- editorial
- Published by Ovid Technologies (Wolters Kluwer Health) in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 25 (5), 879-882
- https://doi.org/10.1161/01.atv.0000164804.05324.8b
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Glycation, Inflammation, and RAGECirculation Research, 2003
- The Pattern Recognition Receptor (RAGE) Is a Counterreceptor for Leukocyte IntegrinsThe Journal of Experimental Medicine, 2003
- The Receptor RAGE as a Progression Factor Amplifying Arachidonate-Dependent Inflammatory and Proteolytic Response in Human Atherosclerotic PlaquesCirculation, 2003
- Receptor for AGE (RAGE) Mediates Neointimal Formation in Response to Arterial InjuryCirculation, 2003
- Central role of RAGE-dependent neointimal expansion in arterial restenosisJCI Insight, 2003
- RAGE Blockade Stabilizes Established Atherosclerosis in Diabetic Apolipoprotein E–Null MiceCirculation, 2002
- Blockade of RAGE–amphoterin signalling suppresses tumour growth and metastasesNature, 2000
- RAGE Mediates a Novel Proinflammatory AxisCell, 1999
- Suppression of accelerated diabetic atherosclerosis by the soluble receptor for advanced glycation endproductsNature Medicine, 1998
- RAGE and amyloid-β peptide neurotoxicity in Alzheimer's diseaseNature, 1996